Alessia Liccardi

879 total citations
21 papers, 389 citations indexed

About

Alessia Liccardi is a scholar working on Epidemiology, Oncology and Neurology. According to data from OpenAlex, Alessia Liccardi has authored 21 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 10 papers in Oncology and 7 papers in Neurology. Recurrent topics in Alessia Liccardi's work include Neuroendocrine Tumor Research Advances (12 papers), Lung Cancer Research Studies (9 papers) and Neuroblastoma Research and Treatments (6 papers). Alessia Liccardi is often cited by papers focused on Neuroendocrine Tumor Research Advances (12 papers), Lung Cancer Research Studies (9 papers) and Neuroblastoma Research and Treatments (6 papers). Alessia Liccardi collaborates with scholars based in Italy and Germany. Alessia Liccardi's co-authors include Annamaria Colao, Chiara Graziadio, Annamaria Colao, Giovanna Muscogiuri, Roberta Modica, Luigi Barrea, Gabriella Pugliese, Rosario Pivonello, Rosa Pirchio and Renata S. Auriemma and has published in prestigious journals such as International Journal of Molecular Sciences, International Journal of Obesity and Obesity Reviews.

In The Last Decade

Alessia Liccardi

18 papers receiving 380 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alessia Liccardi Italy 10 166 95 57 56 49 21 389
Min Min China 14 91 0.5× 36 0.4× 67 1.2× 12 0.2× 117 2.4× 40 494
Yoshihisa Hanayama Japan 10 61 0.4× 30 0.3× 29 0.5× 54 1.0× 73 1.5× 65 358
Elita Stonāne Germany 5 260 1.6× 43 0.5× 33 0.6× 19 0.3× 60 1.2× 8 422
Lynn M. Frydrych United States 8 158 1.0× 38 0.4× 53 0.9× 64 1.1× 69 1.4× 13 418
Smaranda Diaconescu Romania 12 76 0.5× 35 0.4× 43 0.8× 28 0.5× 136 2.8× 72 415
Maryam Afrakhteh Iran 13 141 0.8× 22 0.2× 27 0.5× 27 0.5× 42 0.9× 42 434
Yimei Yin China 7 89 0.5× 94 1.0× 103 1.8× 23 0.4× 61 1.2× 8 563
Jeffrey T. Kirchner United States 11 77 0.5× 29 0.3× 23 0.4× 18 0.3× 27 0.6× 31 409
Byung Ok Kwak South Korea 12 75 0.5× 16 0.2× 30 0.5× 16 0.3× 35 0.7× 36 360

Countries citing papers authored by Alessia Liccardi

Since Specialization
Citations

This map shows the geographic impact of Alessia Liccardi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessia Liccardi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessia Liccardi more than expected).

Fields of papers citing papers by Alessia Liccardi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessia Liccardi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessia Liccardi. The network helps show where Alessia Liccardi may publish in the future.

Co-authorship network of co-authors of Alessia Liccardi

This figure shows the co-authorship network connecting the top 25 collaborators of Alessia Liccardi. A scholar is included among the top collaborators of Alessia Liccardi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessia Liccardi. Alessia Liccardi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Modica, Roberta, et al.. (2025). Tumor Growth Rate in Neuroendocrine Neoplasms: An Additional Tool for Treatment Strategies?. Medicina. 61(10). 1852–1852.
2.
Modica, Roberta, et al.. (2025). Impact of sex hormones on development and progression in NEN: a new therapeutic target?. Endocrine Related Cancer. 32(9).
3.
Modica, Roberta, et al.. (2024). Role of Bone Metastases in Lung Neuroendocrine Neoplasms: Clinical Presentation, Treatment and Impact on Prognosis. International Journal of Molecular Sciences. 25(16). 8957–8957. 2 indexed citations
4.
Modica, Roberta, Anna La Salvia, Alessia Liccardi, et al.. (2024). Dyslipidemia, lipid-lowering agents and neuroendocrine neoplasms: new horizons. Endocrine. 85(2). 520–531. 7 indexed citations
6.
Modica, Roberta, et al.. (2024). Recent advances and future challenges in the diagnosis of neuroendocrine neoplasms. Minerva Endocrinology. 49(2). 158–174. 10 indexed citations
7.
Liccardi, Alessia, Annamaria Colao, & Roberta Modica. (2024). Gender Differences in Lung Neuroendocrine Tumors: A Single-Center Experience. Neuroendocrinology. 115(5). 371–380. 5 indexed citations
8.
Modica, Roberta, et al.. (2023). Vitamin D and Bone Metabolism in Adult Patients with Neurofibromatosis Type 1. Metabolites. 13(2). 255–255. 3 indexed citations
9.
Modica, Roberta, et al.. (2023). Parathyroid diseases and metabolic syndrome. Journal of Endocrinological Investigation. 46(6). 1065–1077. 5 indexed citations
10.
Lania, Andrea, Alberto Ragni, Alessia Liccardi, et al.. (2023). Gastric Neuroendocrine Tumors (g-NETs): A Systematic Review of the Management and Outcomes of Type 3 g-NETs. Cancers. 15(8). 2202–2202. 9 indexed citations
11.
Modica, Roberta, et al.. (2023). Current understanding of pathogenetic mechanisms in neuroendocrine neoplasms. Expert Review of Endocrinology & Metabolism. 19(1). 49–61. 9 indexed citations
13.
Pugliese, Gabriella, Alessia Liccardi, Chiara Graziadio, et al.. (2022). Obesity and infectious diseases: pathophysiology and epidemiology of a double pandemic condition. International Journal of Obesity. 46(3). 449–465. 102 indexed citations
14.
Modica, Roberta, et al.. (2022). Lipid Metabolism and Homeostasis in Patients with Neuroendocrine Neoplasms: From Risk Factor to Potential Therapeutic Target. Metabolites. 12(11). 1057–1057. 14 indexed citations
15.
Auriemma, Renata S., Alessia Liccardi, Nunzia Verde, et al.. (2021). The Vaginal Microbiome: A Long Urogenital Colonization Throughout Woman Life. Frontiers in Cellular and Infection Microbiology. 11. 686167–686167. 69 indexed citations
16.
Auriemma, Renata S., Rosa Pirchio, Alessia Liccardi, et al.. (2021). Metabolic syndrome in the era of COVID-19 outbreak: impact of lockdown on cardiometabolic health. Journal of Endocrinological Investigation. 44(12). 2845–2847. 23 indexed citations
17.
Pivonello, Claudia, Mariarosaria Negri, Roberta Patalano, et al.. (2021). The role of melatonin in the molecular mechanisms underlying metaflammation and infections in obesity: A narrative review. Obesity Reviews. 23(3). e13390–e13390. 24 indexed citations
18.
Auriemma, Renata S., Rosa Pirchio, Alessia Liccardi, et al.. (2020). The Interplay Between Prolactin and Reproductive System: Focus on Uterine Pathophysiology. Frontiers in Endocrinology. 11. 594370–594370. 34 indexed citations
19.
Liccardi, Alessia, et al.. (2019). Active Moderate-to-Severe Graves' Orbitopathy in a Patient With Type 2 Diabetes Mellitus and Vascular Complications. Frontiers in Endocrinology. 9. 810–810. 3 indexed citations
20.
Liccardi, Alessia, Emilia Vergara, Claudio Bellevicine, et al.. (2018). Is the Isthmus Location an Additional Risk Factor for Indeterminate Thyroid Nodules? Case Report and Review of the Literature. Frontiers in Endocrinology. 9. 750–750. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026